Perinatal HIV nearly eradicated in U.S.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 44
- By:
- Publication type:
- Article
Works matching IS 1044307X AND DT 2023 AND VI 35 AND IP 5
Results: 16
1
2
SARS-CoV-2 crosses placenta and infects brains of two infants: 'This is a first'.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 44
- By:
- Publication type:
- Article
3
Study: Prenatal supplements fail to meet nutrient needs.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 43
- By:
- Publication type:
- Article
4
Caring for the aging transgender patient.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 43
- By:
- Publication type:
- Article
5
Canadian Task Force recommendation on screening for postpartum depression misses the mark.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 43
- By:
- Publication type:
- Article
6
Vulvar syringoma.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
7
The diagnostic and therapeutic challenges of syringoma.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 37, doi. 10.12788/obgm.0282
- By:
- Publication type:
- Article
8
sFlt-1:PlGF ratio normal at 24 to 28 weeks: Discontinue aspirin for preterm preeclampsia prevention?
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 35, doi. 10.12788/obgm.0278
- By:
- Publication type:
- Article
9
Hyperlipidemia management: A calibrated approach: Gauge the level of LDL cholesterol and assess risk-enhancing factors for ASCVD--thus setting the table for primary and secondary prevention with medical therapy.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 28, doi. 10.12788/jfp.0576
- By:
- Publication type:
- Article
10
The perimenopausal period and the benefits of progestin IUDs.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 20, doi. 10.12788/obgm.0283
- By:
- Publication type:
- Article
11
Does the current age cutoff for screening miss too many cases of cervical cancer in older women?
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 18, doi. 10.12788/obgm.0277
- By:
- Publication type:
- Article
12
Could epigenetic mechanisms of placental dysregulation explain low birthweight and future cardiometabolic disease?
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 16
- Publication type:
- Article
13
Can whole exome sequencing diagnose genetic causes in cases of severe isolated FGR?
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 15, doi. 10.1002/ijgo.14620
- Publication type:
- Article
14
Whole exome sequencing's role in diagnosing genetic causes of FGR with and without associated anomalies.
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 13, doi. 10.12788/obgm.0280
- By:
- Publication type:
- Article
15
What was the impact of COVID-19 on maternal mortality in the United States?
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 10, doi. 10.12788/obgm.0279
- By:
- Publication type:
- Article
16
Would you prescribe antenatal steroids to a pregnant patient at high risk for delivering at 22 weeks' gestation? For infants born at 22 to 23 weeks' gestation, the combination of a completed course of antenatal steroids plus active support of the newborn at birth optimizes survival, but death and disability are common outcomes for these infants
- Published in:
- OBG Management, 2023, v. 35, n. 5, p. 4, doi. 10.12788/obgm.0281
- By:
- Publication type:
- Article